drugset / Trial / NCT06824051
A Study of Orforglipron (LY3502970) in Adult Participants With Obesity or Overweight
RandomizedParallel-groupDouble-blindTreatment
Summary
The main purpose of this study is to see how orforglipron affects the amount of body fat compared with placebo in participants with obesity or overweight. Participation in the study will last approximately 8 months.
Timeline
- Start
- 2025-02-17
- Primary completion
- 2026-01-26
- Completion
- 2026-01-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Orforglipron | Small molecule | — | Oral |